Lipoedema was first described in 1940 by the American doctors Allen and Hines, who already highlighted the typical fat distribution and the significant physical and psychological impact of this condition. Despite increasing scientific attention, the exact cause has still not been fully clarified. Research focuses, among other things, on genetic predisposition, hormonal influences and abnormalities in the blood and lymphatic systems, but there is still no consensus on the exact cause.
Studies do, however, clearly demonstrate the significant impact on quality of life. In a study by Dr Josef J. Stutz involving 100 lipoedema patients, 80% reported a pain score of 5 or higher, whilst 59% even scored between 7 and 10.
Furthermore, it appears that lipoedema is often not recognised until a late stage. In around 50% of patients, it takes more than ten years for the correct diagnosis to be made, sometimes as long as thirty years. As a result, many patients live with pain and limitations for years without receiving targeted treatment.
Research by Marshall and Schwahn-Schreiber also suggests that around 9.7% of women show signs of lipoedema, indicating that it is a common but still frequently underdiagnosed condition. Early recognition and appropriate treatment are therefore desirable to limit further symptoms.
Following lipoedema treatment with liposuction, there appears to be little to no further accumulation of fat in the tissues and between the cells. Lipoedema treatment can significantly improve quality of life.